Tag Archives: Treatment

Palforzia, If Approved For Peanut Allergy, May Widen Access To A Known Treatment : Shots – Health News – NPR

Enlarge this image Palforzia, a new drug to treat peanut allergies, is expected to get FDA approval. The main ingredient of the drug is peanut flour. Marco Livolsi/EyeEm/Getty Images hide caption toggle caption Marco Livolsi/EyeEm/Getty Images A panel of experts earlier this month recommended that the U.S. Food and Drug Administration approve a new drug… Read More »

FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation

Print this page FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ — Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela is a minimally-absorbed small molecule that acts locally in the… Read More »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More »

Cystic Acne Treatment: What’s Up With Those Large, Painful Pimples That Won’t Go Away? – Self

You’ve probably experienced a few different types of acne since your teenage years, from annoying blackheads to juicy papules. But if you’ve ever developed one of those large, deep, painful red pimples that doesn’t go away, and sometimes never comes to a head, you know it’s a different beast altogether.  If you’ve been slathering your… Read More »

FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis

FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis Print this page SUMMIT, N.J.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved Inrebic (fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.1 “The approval… Read More »